This content is machine translated Bladder Cancer Effective treatment even in advanced stages Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
View Post 6 min This content is machine translated Melanoma in advanced stages Treatment strategies in the adjuvant and neoadjuvant setting The introduction of checkpoint inhibitors and targeted therapy with kinase inhibitors revolutionized the treatment options for patients with advanced-stage melanoma. While there is already a lot of evidence for immunotherapy…
View Post 4 min This content is machine translated Gastroesophageal tumors Therapy in the metastatic stage of esophageal and gastric carcinomas The new era of immunotherapy has successfully arrived in the treatment of all metastatic/locally advanced esophageal gastric carcinomas . Recent approvals of immune checkpoint inhibitors (ICI) enrich the therapeutic landscape in almost…
View Post 5 min This content is machine translated Immunotherapy Untapped potential in early disease stages Over the last decade, immunotherapy using checkpoint inhibitors has become established in the treatment of many oncological conditions. Especially in advanced tumor disease, ipilimumab, nivolumab and co. play a significant…
View Post 5 min This content is machine translated Non-resectable gastric carcinoma Immunotherapy on the rise The prognosis of advanced gastric carcinoma remains extremely unfavorable. Accordingly, new treatment approaches are urgently needed. Current evidence suggests that checkpoint inhibitor therapy may become more important in the near…
View Post 8 min This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
